A high frequency of CDO1 promoter methylation in colon cancer was then identified when compared with normal colon, and findings were extended to several other malignancies, including breast, esophagus, lung, bladder, and gastric cancer. The gene discussed is CDO1; the disease is colonic neoplasm.